
VMD acquires Elegance
Vision Marketing & Distribution (VMD) has acquired Elegance in Eyewear/Euro Optics, with Elegance’s former owner Carl Doherty staying on as general manager for the new division.

Vision Marketing & Distribution (VMD) has acquired Elegance in Eyewear/Euro Optics, with Elegance’s former owner Carl Doherty staying on as general manager for the new division.

The School of Optometry and Vision Science (SOVS), University of Auckland, is hosting the 16th Scientific and 10th Educators’ Meeting in Optometry (SEMO) Thursday 16 to Saturday 18 April 2020.

From football hero to global style icon, UNICEF ambassador to family man, the multi-faceted brand David Beckham juggernaut has launched fragrance, skincare and now, eyewear.

Dr Kate Gifford Why the passion for myopia? Right from my university days, I was interested in both contact lenses and binocular vision/paediatrics. My final year research project was on ortho-k and,

Optometry Western Australia's annual conference Western Australian Vision Education (Wave) is back at the Esplanade Hotel, Fremantle, Saturday 21 to Sunday 22 March 2020.

An impressive 98% of Serengeti’s sunglass range is available in prescription +6.00 to -8.00 (cylinder 4.00), making the range particularly popular with prescription wearers. Its Variodrive lenses are up to 72% thinner and 45% lighter than conventional prescription lenses, said Serengeti and Bollé Au

Scientists from Japan’s Tohoku University have created a battery-driven self-moisturising contact lens to combat dry eye symptoms associated with daily contact lens wear.

Major disruption is on the cards for New Zealand’s physical pharmacies, with new digital providers PillDrop and Zoom Pharmacy entering the market and retail giant Amazon possibly on the horizon.

The Eyewear Forum and LOFT Eyewear Shows have announced the nominees for the 2020 edition of the LOFTxTEF Excellence in Eyewear Design awards. A jury of optical journalists, influencers and opticians

University of Auckland doctoral student Neera Jain is calling for medical schools to re-evaluate their expectations of people with disabilities and their image of the ‘ideal’ physician, in a bid to over-turn outdated views and break down barriers for disabled people in medicine.

The latest Cochrane review concurs with recent myopia studies, identifying atropine as most effective in slowing myopia progression.

A new, higher dose aflibercept (Eylea) 8mg formulation took one step closer to becoming a treatment reality with news that phase III trials will start later this year.